Pervasive Weakness In Mismanaged Delaware Conglomerate Revealed by DuPont CFO in Chicago Today
Good Afternoon, Bonsoir, Guten Abend, Buona Sera,
Investors, anyone who has followed this shrinking chemical conglomerate during the 21st century knows to expect disappointment after disappointment. This morning, June 13, 2013, Ms. Kullman's numbers hack, DuPont CFO Nicholas FeignandFakeUs is full of Holliday-like hokum. Here's his fluff on DuPont "strategic priorities" delivered at the Deutsche Bank Conference on Materials in Chicago:
"Extending its leadership in high-value, science-driven segments of the agriculture-to-food value chains;
"Strengthening and growing DuPont's leading position as a provider of differentiated, high-value advanced materials, and;
" Developing world-leading industrial biotechnology capabilities that create transformational, new bio-based businesses."
FeignandFakeUs uses all this meaningless verbosity and bombastic vagueness to downplay what he grudgingly has to admit:
DuPont's earnings per share are going south in the first half of 2013, DOWN 10% year-over-year notwithstanding an increasingly strengthening global economy. Way to go, DuPont Senior Management. Imprelis, Tell Us!
Merely the afternoon commentary of one individual investor and long-time student of the deteriorating